The Role of Extracellular Vesicles (EVs) in Chronic Graft vs. Host Disease, and the Potential Function of Placental Cell-Derived EVs as a Therapeutic Tool

The Role of Extracellular Vesicles (EVs) in Chronic Graft vs. Host Disease, and the Potential Function of Placental Cell-Derived EVs as a Therapeutic Tool

Chronic graft-versus-host disease (cGVHD) presents with dermal inflammation and fibrosis. We investigated the characteristics of extracellular vesicles (EVs) obtained from cGVHD patients, and their potential effects on human dermal fibroblast (NHDF) cells. The anti-inflammatory and anti-fibrotic eff...

Full description

Bibliographic Details
Main Authors:	Aharon, A. (Author), Amit, O. (Author), Avivi, I. (Author), Bar-Lev, T.H (Author), Dangot, A. (Author), Ram, R. (Author), Zavaro, M. (Author)
Format:	Article
Language:	English
Published:	MDPI 2023
Subjects:	chronic graft-versus-host diseases (cGVHD) exosome Extracellular Vesicles extracellular vesicles (EVs) female Female fibrosis Fibrosis graft versus host reaction Graft vs Host Disease human Humans inflammation Inflammation metabolism pathology placenta Placenta pregnancy Pregnancy transforming growth factor beta Transforming Growth Factor beta
Online Access:	View Fulltext in Publisher View in Scopus

Similar Items

HPV32‐related Heck’s disease in a chronic graft‐versus‐host disease patient with long‐term successful KTP laser treatment: A rare case report
by: Joe Truong Nguyen, et al.
Published: (2021-05-01)

Individual Immune-Modulatory Capabilities of MSC-Derived Extracellular Vesicle (EV) Preparations and Recipient-Dependent Responsiveness
by: Lambros Kordelas, et al.
Published: (2019-04-01)

Novel insights into MSC-EVs therapy for immune diseases
by: Peilong Lai, et al.
Published: (2019-03-01)

Investigating host versus donor T cell chimerism in cutaneous graft versus host disease
by: Khatib, Laila
Published: (2020)

Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease
by: Rachel E. Crossland, et al.
Published: (2017-11-01)

Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease
by: Rachel E. Crossland, et al.
Published: (2020-12-01)

Biomarkers in graft versus host disease after allogeneic hematopoietic stem cell transplant
by: Geary, Joshua J.
Published: (2016)

ORAL GRAFT VERSUS HOST DISEASE: A REVIEW
by: Reddy Lavanya, et al.
Published: (2016-03-01)

Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
by: Tik Shing Cheung, et al.
Published: (2020-06-01)

Graft versus host disease occurring in living donor liver transplant
by: Nalini Bansal, et al.
Published: (2018-01-01)

Hydrogen in Patients With Corticosteroid-Refractory/Dependent Chronic Graft-Versus-Host-Disease: A Single-Arm, Multicenter, Open-Label, Phase 2 Trial
by: Liren Qian, et al.
Published: (2020-11-01)

Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?
by: Luciana De Luca, et al.
Published: (2017-05-01)

Enfermedad injerto contra huesped: sus manifestaciones bucales
by: Claudia Marcela Hernández Cancino, et al.

A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD
by: Peilong Lai, et al.
Published: (2018-12-01)

Lichenoid variant of chronic cutaneous graft versus host reaction post blood transfusion: A rare event post blood transfusion
by: Pushpa Kodipalya Ramakrishnaiah, et al.
Published: (2015-01-01)

Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation
by: Kelly, Debra
Published: (2014)

Female urethral stricture from chronic graft-versus-host disease
by: James Roy, et al.
Published: (2021-01-01)

Local immune cell infiltration in cutaneous acute graft versus host disease
by: Rachel Sennett, MD, PhD, et al.
Published: (2020-09-01)

Study on the role of CD4⁺CD25⁺ regulatory T cells in acute and chronicgraft-versus-host disease in murine models
by: Shao, Liang, et al.
Published: (2013)

Histology and immunopathology of skin and rectum following bone marrow transplantation
by: Sviland, Lisbet
Published: (1989)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
by: Sena Kim, et al.
Published: (2020-06-01)

NOTCH and Graft-Versus-Host Disease
by: Mauro Di Ianni, et al.
Published: (2018-08-01)

ST2/MYD88 signaling is a therapeutic target alleviating murine acute graft-versus-host disease sparing T regulatory cell function
by: Griesenauer, Brad
Published: (2018)

The Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles on Hematopoietic Stem Cells Fate
by: Hamze Timari, et al.
Published: (2017-12-01)

Novel elucidation and treatment of pancreatic chronic graft-versus-host disease in mice
by: Shin Mukai, et al.
Published: (2018-01-01)

DISTINCT T CELL CLONES ARE ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE (GVHD), AND POTENTIALLY GRAFT-VERSUS-TUMOR (GVT), RESPONSES FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION
by: Berrie, Jennifer
Published: (2011)

Charakterisierung der Homing-Rezeptor-Expression nach allogener Stammzelltransplantation - neue Biomarker für eine akute Graft-versus-Host-Disease?
by: Umrath, Veronika
Published: (2013)

"PREDICTIVE SIGNIFICANCE OF SERUM INTERLEUKIN-10 FOR ACUTE GRAFT VERSUS HOST DISEASE PRIOR TO ALLOGENEIC BONE MARROW TRASPLANTATION "
by: M. Iravani, et al.
Published: (2005-06-01)

Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading?
by: Xiao-Su Zhao, et al.
Published: (2019-08-01)

Azithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial
by: Maryam Barkhordar, et al.
Published: (2018-04-01)

"PREDICTIVE SIGNIFICANCE OF SERUM INTERLEUKIN-10 FOR ACUTE GRAFT VERSUS HOST DISEASE PRIOR TO ALLOGENEIC BONE MARROW TRASPLANTATION "
by: M. Iravani, et al.
Published: (2005-06-01)

THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
by: Lucrezia Laterza, et al.
Published: (2016-05-01)

Evaluation of risk for graft-versus-host disease in children who receive less than the full doses of mini-dose methotrexate for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation
by: Sook Kyung Yum, et al.
Published: (2013-11-01)

An update on the clinical utility of extracorporeal photopheresis in the treatment of graft-versus-host disease
by: Salem B, et al.
Published: (2017-03-01)

MSCs Become Collagen-Type I Producing Cells with Different Phenotype in Allogeneic and Syngeneic Bone Marrow Transplantation
by: Robert Maximilian Rusch, et al.
Published: (2021-05-01)

Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease
by: Jan Weile, et al.
Published: (2013-05-01)

GVHD amelioration by human bone marrow mesenchymal stromal/stem cell-derived extracellular vesicles is associated with peripheral preservation of naive T cell populations
by: Fujii, Sumie
Published: (2018)

Biomarkers for Allogeneic HCT Outcomes
by: Djamilatou Adom, et al.
Published: (2020-04-01)

MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease
by: Christian Koenecke, et al.
Published: (2018-05-01)

Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation
by: Stokes, Jessica, et al.
Published: (2016)